Evidence map›Paper›PMID 27001024›Full record

ArticleFEBS letters2016

Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacity.

Marion E Weir, Jacqueline E Mann, Thomas Corwin, Zachary W Fulton, Jennifer M Hao, Jeanine F Maniscalco, Marie C Kenney, Kristal M Roman Roque, Elizabeth F Chapdelaine, Ulrich Stelzl and 3 more

Open access · bronzeAbstract readLetter
In one paragraph

Article in FEBS letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ExploringMicrobial cell (Graz, Austria) · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Marion E WeirDepartment of Biology, University of Vermont, Burlington, VT, USA.
Jacqueline E MannDepartment of Medical Laboratory and Radiation Sciences, University of Vermont, Burlington, VT, USA.
Thomas CorwinOtto-Warburg Laboratory, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Zachary W FultonDepartment of Biology, University of Vermont, Burlington, VT, USA.
Jennifer M HaoDepartment of Biology, University of Vermont, Burlington, VT, USA.
Jeanine F ManiscalcoDepartment of Biology, University of Vermont, Burlington, VT, USA.
Marie C KenneyDepartment of Biology, University of Vermont, Burlington, VT, USA.
Kristal M Roman RoqueDepartment of Biology, University of Vermont, Burlington, VT, USA.
Elizabeth F ChapdelaineDepartment of Biology, University of Vermont, Burlington, VT, USA.
Ulrich StelzlOtto-Warburg Laboratory, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Paula B DemingDepartment of Medical Laboratory and Radiation Sciences, University of Vermont, Burlington, VT, USA.
Bryan A BallifDepartment of Biology, University of Vermont, Burlington, VT, USA.
Karen L HinkleDepartment of Biology, University of Vermont, Burlington, VT, USA.
University of Vermont · USMax Planck Institute for Molecular Genetics · DENorwich University · USUniversity of Vermont Medical Center · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI SPEES, JEFFREY L · 2001 to 2010
$23.5M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HILL, JACK · 2006 to 2011
$14.5M
Center for Neuroscience ExcellenceP30GM103498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2012 to 2015
$4.3M
NCRR NIH HHS P20 RR016435NCRR NIH HHS P20 RR021905NIGMS NIH HHS P20 GM103449NIGMS NIH HHS P30 GM103498
6 · The paper itself

Abstract

Src family tyrosine kinases (SFKs) are critical players in normal and aberrant biological processes. While phosphorylation importantly regulates SFKs at two known tyrosines, large-scale phosphoproteomics have revealed four additional tyrosines commonly phosphorylated in SFKs. We found these novel tyrosines to be autophosphorylation sites. Mimicking phosphorylation at the C-terminal site to the activation loop decreased Fyn activity. Phosphomimetics and direct phosphorylation at the three SH2 domain sites increased Fyn activity while reducing phosphotyrosine-dependent interactions. While 68% of human SH2 domains exhibit conservation of at least one of these tyrosines, few have been found phosphorylated except when found in cis to a kinase domain.

Indexed as

src Homology DomainsAmino AcidsConserved SequenceHEK293 CellsHumansMass SpectrometryPhosphorylationPhosphotyrosineProtein BindingProto-Oncogene Proteins c-fynSaccharomyces cerevisiaesrc-Family KinasesStructure-Activity RelationshipAmino AcidsPhosphotyrosineProto-Oncogene Proteins c-fynsrc-Family Kinasesmass spectrometryphosphorylationSrc family kinase

Identifiers

PMID27001024
PMCPMC4844773
OpenAlexW2308778564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.